Esther Elishaev
No ORCID on file
· 45 papers in corpus
· active 2010-2025
Study types
- preprint 27
- article 13
- other 3
- supplementary-materials 2
Condition tags
- endometriosis 43
- adenomyosis 2
Top journals
- Clinical cancer research : an official journal of the American Association for Cancer Research 3
- Annals of clinical and laboratory science 1
- Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1
- Cancer research 1
- Hormones & cancer 1
Frequent coauthors
- Anda M Vlad 38
- Nicole Donnellan 33
- Robert P. Edwards 32
- Raluca A. Budiu 29
- Suketu Mansuria 29
- Swati Suryawanshi 29
- Xin Huang 28
- Ted Lee 28
- Gina Mantia-Smaldone 27
- George C. Tseng 24
other
2025
BACKGROUND: Ovarian high-grade serous carcinomas (HGSC) comprise four distinct molecular subtypes based on mRNA expression patterns, with differential survival. Understanding risk factor associations is important to elucidate the etiology o…
article
2025
Supplementary figures and table
article
2024
article
2023
preprint
2023
AbstractPurpose: Mechanisms of immune dysregulation associated with advanced tumors are relatively well understood. Much less is known about the role of immune effectors against cancer precursor lesions. Endometrioid and clear-cell ovarian …
preprint
2023
AbstractPurpose: Mechanisms of immune dysregulation associated with advanced tumors are relatively well understood. Much less is known about the role of immune effectors against cancer precursor lesions. Endometrioid and clear-cell ovarian …
preprint
2023
AbstractOvarian clear cell carcinoma (OCCC) is a deadly and treatment-resistant cancer, which arises within the unique microenvironment of endometriosis. In this study, we identified a subset of endometriosis-derived mesenchymal stem cells …
preprint
2023
AbstractOvarian clear cell carcinoma (OCCC) is a deadly and treatment-resistant cancer, which arises within the unique microenvironment of endometriosis. In this study, we identified a subset of endometriosis-derived mesenchymal stem cells …
preprint
2023
AbstractPurpose: Endometriosis, a largely benign, chronic inflammatory disease, is an independent risk factor for endometrioid and clear cell epithelial ovarian tumors. We aimed to identify plasma miRNAs that can be used to differentiate pa…
preprint
2023
AbstractPurpose: Endometriosis, a largely benign, chronic inflammatory disease, is an independent risk factor for endometrioid and clear cell epithelial ovarian tumors. We aimed to identify plasma miRNAs that can be used to differentiate pa…
preprint
2023
Supplementary figures and table
preprint
2023
Supplementary figures and table
preprint
2023
PDF file - 488K, Supplementary Figure 1: Experimental design. Supplementary Figure 2. Reliability of RNA extraction and reproducibility of RTqPCR techniques. Supplementary Figure 3. Reliability of RT-qPCR assays. Supplementary Figure 4. miR…
preprint
2023
PDF file - 488K, Supplementary Figure 1: Experimental design. Supplementary Figure 2. Reliability of RNA extraction and reproducibility of RTqPCR techniques. Supplementary Figure 3. Reliability of RT-qPCR assays. Supplementary Figure 4. miR…
preprint
2023
Supplementary Materials and Methods
preprint
2023
Supplementary Materials and Methods
supplementary-materials
2023
PDF file - 36K, Supplementary Table 1. Demographic and clinical characteristics of the study cohort. Supplementary Table 2. List of the 24 miRNAs identified by genome-wide plasma miRNA expression profiling from healthy controls (n=6), endom…
supplementary-materials
2023
PDF file - 36K, Supplementary Table 1. Demographic and clinical characteristics of the study cohort. Supplementary Table 2. List of the 24 miRNAs identified by genome-wide plasma miRNA expression profiling from healthy controls (n=6), endom…
preprint
2023
Suppl Fig S1. Venn diagram of DE genes from 3 group comparisons
preprint
2023
Suppl Fig S1. Venn diagram of DE genes from 3 group comparisons
preprint
2023
Suppl Fig S2. Kras and Pten pathways in relationship to complement gene expression
preprint
2023
Suppl Fig S2. Kras and Pten pathways in relationship to complement gene expression
preprint
2023
Suppl Fig S3. Antibody-mediated, complement-induced cytotoxicity
preprint
2023
Suppl Fig S3. Antibody-mediated, complement-induced cytotoxicity
preprint
2023
Suppl Fig S4. Complement and non-target siRNA